Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1344016 | 0.89 | ATM (0.44) | TDP1LMNAATMHCAR2ALDH1A1 | |
| SCHEMBL4621786 | 0.86 | HCAR2 (0.42) | TDP1LMNAATMHCAR2ALDH1A1 | |
| SCHEMBL5580247 | 0.86 | HCAR2 (0.42) | TDP1LMNAATMHCAR2ALDH1A1 | |
| SCHEMBL35691 | 0.84 | LMNA (0.38) | TDP1LMNAATMHCAR2CHRNB2 | |
| SCHEMBL2475190 | 0.84 | TDP1 (0.56) | TDP1LMNAATMCA12CA1 | |
| SCHEMBL2475186 | 0.84 | TDP1 (0.56) | TDP1LMNAATMCA12CA1 | |
| SCHEMBL2478667 | 0.84 | TDP1 (0.56) | TDP1LMNAATMCA12CA1 | |
| SCHEMBL168359 | 0.81 | TSHR (0.53) | TDP1LMNAATMHCAR2ALDH1A1 | |
| SCHEMBL35725 | 0.80 | ATM (0.37) | TDP1LMNAATMHCAR2ALDH1A1 | |
| SCHEMBL182416 | 0.79 | TDP1 (0.51) | TDP1LMNAATMCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111278938-B | Toughened low odor/low bloom cyanoacrylate compositions | 汉高股份有限及两合公司 | 2023-06-20 | — | — | CN | claimed |
| CN-111278878-B | Cyanoacrylate compositions | 汉高股份有限及两合公司 | 2022-08-26 | — | — | CN | claimed |
| EP-3700950-A1 | CYANOACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2020-09-02 | — | — | EP | claimed |
| EP-3700991-A1 | TOUGHENED, LOW ODOR/LOW BLOOM CYANOACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2020-09-02 | — | — | EP | claimed |
| US-20200255693-A1 | TOUGHENED, LOW ODOR/LOW BLOOM CYANOACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2020-08-13 | — | — | US | claimed |
| US-20200255692-A1 | CYANOACRYLATE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2020-08-13 | — | — | US | claimed |
| CN-111278938-A | Toughened low odor/low blooming cyanoacrylate compositions | 汉高知识产权控股有限责任公司 | 2020-06-12 | — | — | CN | claimed |
| CN-111278878-A | Cyanoacrylate compositions | 汉高知识产权控股有限责任公司 | 2020-06-12 | — | — | CN | claimed |
| WO-2013129722-A1 | TISSUE ADHESIVE FOR WOUND CLOSURE AND PREPARATION METHOD THEREOF | GENEWEL CO., LTD (KR) | 2013-09-06 | — | — | WO | claimed |
| EP-1455738-B1 | USE OF ELECTROPHILIC MONOMERS FOR HAIR TREATMENT | OREAL (FR) | 2010-07-28 | — | — | EP | claimed |
| US-20060083706-A1 | Haircare composition comprising at least one electrophilic monomer and micro- or nanoparticles of at least one solid lubricant | L'OREAL S.A. (FR) | 2006-04-20 | — | — | US | claimed |
| US-20060078523-A1 | Composition comprising at least one electrophilic monomer and at least one acid in a cosmetically acceptable anhydrous medium, and use thereof for cosmetic treatment of the hair | L'OREAL S.A. (FR) | 2006-04-13 | — | — | US | claimed |
| US-20060078522-A1 | Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt | L'OREAL S.A. (FR) | 2006-04-13 | — | — | US | claimed |
| US-20050271694-A1 | Novel modification of medical prostheses | BAYLOR COLLEGE OF MEDICINE | 2005-12-08 | — | — | US | claimed |
| WO-2005096990-A2 | NOVEL MODIFICATION OF MEDICAL PROSTHESES | BAYLOR COLLEGE OF MEDICINE (US) | 2005-10-20 | — | — | WO | claimed |
| US-20030175229-A1 | Electrophilic monomers for treating the hair | L'OREAL (FR) | 2003-09-18 | — | — | US | claimed |
| US-5665107-A | Surface opening adhesive sealer | HEMODYNAMICS, INC. (US) | 1997-09-09 | — | — | US | claimed |
| US-5653730-A | Surface opening adhesive sealer | HEMODYNAMICS, INC. (US) | 1997-08-05 | — | — | US | claimed |
| US-5529577-A | Surface opening adhesive sealer | HEMODYNAMICS, INC. (US) | 1996-06-25 | — | — | US | claimed |
| US-5383899-A | Method of using a surface opening adhesive sealer | HEMODYNAMICS, INC. | 1995-01-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030175229-A1 | Electrophilic monomers for treating the hair | NACA, SUCLG1, TYR | TDP1 2889/4885LMNA 2677/4885ATM 4413/4885 |
| US-20060083706-A1 | Haircare composition comprising at least one electrophilic monomer and micro- or nanoparticles of at least one solid lubricant | MITF, CUTA, NACA | TDP1 3846/4885LMNA 2622/4885ATM 3370/4885 |
| US-20060078523-A1 | Composition comprising at least one electrophilic monomer and at least one acid in a cosmetically acceptable anhydrous medium, and use thereof for cosmetic treatment of the hair | HOGA1, OAT, SUCLG1 | TDP1 2334/4885LMNA 3450/4885ATM 2695/4885 |
| US-20060078522-A1 | Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt | KRT18, DSG1, DSC1 | TDP1 3699/4885LMNA 1665/4885ATM 1556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.